Price T Rowe Associates Inc Idexx Laboratories Inc Transaction History

Price T Rowe Associates Inc

$867 Billion
Q4 2024

A detailed history of Price T Rowe Associates Inc transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,162,947 shares of IDXX stock, worth $517 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,162,947

Previous 1,536,852 24.33%

Holding current value

$517 Million

Previous $776 Million 38.08%

% of portfolio

0.06%

Previous 0.09%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$406.92 - $495.42 $152 Million - $185 Million	-373,905 Reduced 24.33%	1,162,947 $481 Million
Q3 2024 Nov 14, 2024	BUY	$455.08 - $517.19 $121 Million - $138 Million	265,970 Added 20.93%	1,536,852 $776 Million
Q2 2024 Aug 14, 2024	BUY	$468.04 - $548.53 $465 Million - $545 Million	993,366 Added 357.95%	1,270,882 $619 Million
Q1 2024 May 15, 2024	BUY	$515.08 - $576.87 $46,357 - $51,918	90 Added 0.03%	277,516 $150 Million
Q4 2023 Feb 14, 2024	BUY	$391.37 - $557.56 $6.46 Million - $9.2 Million	16,503 Added 6.32%	277,426 $154 Million
Q3 2023 Nov 14, 2023	BUY	$432.42 - $556.67 $22.9 Million - $29.4 Million	52,903 Added 25.43%	260,923 $114 Million
Q2 2023 Aug 14, 2023	BUY	$450.7 - $503.61 $15.4 Million - $17.2 Million	34,108 Added 19.61%	208,020 $104 Million
Q1 2023 May 15, 2023	SELL	$406.01 - $514.59 $61,307 - $77,703	-151 Reduced 0.09%	173,912 $87 Million
Q4 2022 Feb 14, 2023	SELL	$324.64 - $441.27 $7.07 Million - $9.61 Million	-21,779 Reduced 11.12%	174,063 $71 Million
Q3 2022 Nov 14, 2022	SELL	$325.8 - $407.78 $214 Million - $267 Million	-655,708 Reduced 77.0%	195,842 $63.8 Million
Q2 2022 Aug 15, 2022	SELL	$327.37 - $553.44 $71.3 Million - $120 Million	-217,711 Reduced 20.36%	851,550 $299 Million
Q1 2022 May 16, 2022	BUY	$466.52 - $631.01 $173 Million - $234 Million	370,413 Added 53.0%	1,069,261 $585 Million
Q4 2021 Feb 14, 2022	SELL	$586.54 - $666.48 $11.8 Million - $13.4 Million	-20,055 Reduced 2.79%	698,848 $460 Million
Q3 2021 Nov 15, 2021	SELL	$621.9 - $705.76 $8.02 Million - $9.1 Million	-12,888 Reduced 1.76%	718,903 $447 Million
Q2 2021 Aug 16, 2021	SELL	$486.36 - $637.08 $264 Million - $346 Million	-542,742 Reduced 42.58%	731,791 $462 Million
Q1 2021 May 17, 2021	SELL	$465.18 - $551.79 $343 Million - $407 Million	-737,860 Reduced 36.67%	1,274,533 $624 Million
Q4 2020 Feb 16, 2021	BUY	$383.85 - $499.87 $772 Million - $1.01 Billion	2,012,393 New	2,012,393 $1.01 Billion

Others Institutions Holding IDXX

# of Institutions

1,219

Shares Held

72.2M

Call Options Held

155K

Put Options Held

318K

View Full List

About IDEXX LABORATORIES INC

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $37B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

More about IDXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Idexx Laboratories Inc Transaction History